D. Ellis

发表

Natural habitat of Cryptococcus neoformans var. gattii

D. Ellis, T. Pfeiffer, 1990, Journal of clinical microbiology.

T. Sorrell, D. Ellis, T. Pfeiffer, 1992, European Journal of Epidemiology.

Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

J. Perfect, M. Ghannoum, W. Schell, 2004, Journal of Clinical Microbiology.

Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and Caspofungin

M. Pfaller, D. Ellis, S. Messer, 2007, Journal of Clinical Microbiology.

Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients

D. Marriott, T. Sorrell, W. Meyer, 2009, Pediatrics.

Treatment of a critically ill child with disseminated Candida glabrata with a recombinant human antibody specific for fungal heat shock protein 90 and liposomal amphotericin B, caspofungin, and voriconazole

D. Ellis, A. Sutherland, 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Active Surveillance of Candidemia, Australia

D. Marriott, T. Sorrell, D. Ellis, 2006, Emerging infectious diseases.

Divergence Among an International Population of Trichophyton tonsurans Isolates

J. S. Leeder, S. Abdel‐Rahman, T. Sugita, 2009, Mycopathologia.

Candida albicans Strain Maintenance, Replacement, and Microvariation Demonstrated by Multilocus Sequence Typing

D. Shaw, M. Maiden, N. Gow, 2006, Journal of Clinical Microbiology.

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

A. Rodloff, M. Pfaller, D. Ellis, 2010, Journal of Clinical Microbiology.

Ultrastructure of thermophilic fungi: I. Ascocarp morphology of Thermoascus aurantiacus

D. Ellis, 1981 .

Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp.

D. Marriott, T. Sorrell, D. Ellis, 2008, Critical care medicine.

Thalidomide: a novel therapy for microsporidiosis.

B. Gazzard, D. Sharpstone, D. Ellis, 1997, Gastroenterology.

The role of clinical mycology reference laboratories

S. Kidd, D. Ellis, C. Halliday, 2015 .

Amphotericin B: spectrum and resistance.

D. Ellis, 2002, The Journal of antimicrobial chemotherapy.

Successful treatment of phaeohyphomycotic keratitis caused by Bipolaris australiensis

D. Ellis, R. Raju, T. Henderson, 2008, Clinical & experimental ophthalmology.

Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

K. Byth, D. Marriott, T. Sorrell, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Natural environmental sources of Cryptococcus neoformans var. gattii

T. Sorrell, D. Ellis, T. Pfeiffer, 1996, Journal of clinical microbiology.

Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis.

D. Ellis, T. Pfeiffer, 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA — a pilot study to standardize techniques on which to base a detailed epidemiological survey

T. Sorrell, W. Meyer, D. Ellis, 1999, Electrophoresis.

Environmental isolation of Cryptococcus neoformans gattii from California.

D. Ellis, T. Pfeiffer, David Ellis, 1991, The Journal of infectious diseases.

Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii

B. Wickes, K. Kwon-Chung, D. Ellis, 1992, Infection and immunity.

Ecology, life cycle, and infectious propagule of Cryptococcus neoformans

D. Ellis, T. Pfeiffer, 1990, The Lancet.

Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting

T. Sorrell, W. Meyer, D. Ellis, 1996, Journal of clinical microbiology.

Epidemiology: surveillance of fungal infections.

D. Marriott, R. Barton, W. Meyer, 2000, Medical mycology.

Cryptococcus neoformans var. gattii in Australia

D. Ellis, 1987, Journal of clinical microbiology.

Identification and characterization of VNI/VNII and novel VNII/VNIV hybrids and impact of hybridization on virulence and antifungal susceptibility within the C-neoformans/C-gattii species

T. Sorrell, W. Meyer, M. Cogliati, 2017 .

Identification and Characterization of VNI/VNII and Novel VNII/VNIV Hybrids and Impact of Hybridization on Virulence and Antifungal Susceptibility Within the C. neoformans/C. gattii Species Complex

T. Sorrell, W. Meyer, M. Cogliati, 2016, PloS one.

The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis

Christina A. Cuomo, A. Casadevall, J. Perfect, 2017, mSphere.

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.

M. Mallié, R. Barton, Shan-Chwen Chang, 2010, Diagnostic microbiology and infectious disease.

Chiral Stability Study of Oral Liquid Clopidogrel Formulations for Infants

R. Milne, D. Ellis, T. Rozek, 2012 .

Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre® YeastOne® for Candida albicans: a prospective observational cohort study.

T. Sorrell, D. Ellis, M. Slavin, 2014, The Journal of antimicrobial chemotherapy.

Support for the EUCASTand revised CLSI fluconazole clinical breakpoints by Sensititre w YeastOne w for Candida albicans : a prospective observational cohort study

T. Sorrell, D. Ellis, M. Slavin, 2014 .

Impact of antifungal resistance in Australia

T. Sorrell, D. Ellis, S. Chen, 2007 .

Determinants of mortality in non-neutropenic ICU patients with candidaemia

D. Marriott, T. Sorrell, D. Ellis, 2009, Critical care.

Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing

T. Sorrell, Huiping Wang, D. Ellis, 2009, BMC Microbiology.

Ecology of Cryptococcus neoformans.

T. Sorrell, D. Ellis, 1997, Revista iberoamericana de micologia.

Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts.

T. Sorrell, D. Fisher, B. Currie, 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience

D. Ellis, M. Slavin, Q. Nguyen, 2009, Transplant infectious disease : an official journal of the Transplantation Society.

The potential for terbinafine in non-dermatophyte fungal infections with or without skin involvement

D. Ellis, 1998 .

Recent advances in biology and immunology of Cryptococcus neoformans.

F. Dromer, T. Kozel, I. Polacheck, 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

In Vitro Antifungal Activities of Bis(Alkylpyridinium)Alkane Compounds against Pathogenic Yeasts and Molds

T. Sorrell, K. Jolliffe, D. Obando, 2010, Antimicrobial Agents and Chemotherapy.

International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database--the quality controlled standard tool for routine identification of human and animal pathogenic fungi.

Gianluigi Cardinali, Duong Vu, Walter Gams, 2015, Medical mycology.

Rapid Identification and Differentiation of Trichophyton Species, Based on Sequence Polymorphisms of the Ribosomal Internal Transcribed Spacer Regions, by Rolling-Circle Amplification

T. Sorrell, D. Ellis, F. Kong, 2008, Journal of Clinical Microbiology.

Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients

D. Ellis, I. Lutsar, P. Troke, 2008, Antimicrobial Agents and Chemotherapy.

Clinical, pathologic and epidemiologic features of infection with Scedosporium prolificans: four cases and review

D. Ellis, R. Andrews, I. Gosbell, 1999 .

Recommendations for the treatment of established fungal infections

T. Sorrell, D. Shaw, D. Ellis, 2008, Internal medicine journal.

Hexadecylphosphocholine (Miltefosine) Has Broad-Spectrum Fungicidal Activity and Is Efficacious in a Mouse Model of Cryptococcosis

T. Sorrell, D. Obando, D. Ellis, 2006, Antimicrobial Agents and Chemotherapy.

Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection.

T. Sorrell, L. Delhaes, W. Meyer, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Presence of α and a Mating Types in Environmental and Clinical Collections of Cryptococcus neoformans var. gattii Strains from Australia

M. Krockenberger, D. Ellis, R. Malik, 1999, Journal of Clinical Microbiology.

Cryptococcosis and the Ecology of Cryptococcus neoformans

D. Ellis, T. Pfeiffer, 1994 .

A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group.

J. Meis, D. Ellis, J. Billé, 2000, Diagnostic microbiology and infectious disease.

Quality Control Limits for Voriconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue

J. Meis, M. Pfaller, D. Ellis, 2004, Journal of Clinical Microbiology.

Quality Control Limits for Fluconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue

J. Meis, M. Pfaller, D. Ellis, 2003, Journal of Clinical Microbiology.

Entomophthoromycosis caused by Basidiobolus ranarum in tropical northern Australia.

B. Currie, D. Ellis, Joshua S. Davis, 2012, Pathology.

Late‐onset post‐traumatic Phaeoacremonium parasiticum endophthalmitis

D. Ellis, Lawrence R. Lee, T. Huynh, 2007, Clinical & experimental ophthalmology.

Ultrastructure of thermophilic fungi: VI. General discussion

D. Ellis, 1982 .

Ultrastructure of thermophilic fungi III. Ascocarp morphology of Chaetomium thermophile and C. gracile

D. Ellis, 1981 .

Ultrastructure of thermophilic fungi: V. Conidial ontogeny in Humicola grisea var. thermoidea and H. insolens

D. Ellis, 1982 .

Ultrastructure of thermophilic fungi IV. Conidial ontogeny in Thermomyces

D. Ellis, 1981 .

Teaching medical mycology in the year 2000.

J. Graybill, D. Ellis, R. Negroni, 1998, Medical mycology.

Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.

D. Marriott, T. Sorrell, W. Meyer, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Cutaneous zygomycosis caused by Saksenaea vasiformis following water‐related wound in a 24‐year‐old immunocompetent woman

D. Ellis, B. Howden, N. Holmes, 2009, Mycoses (Berlin).

Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.

D. Marriott, T. Sorrell, D. Ellis, 2010, The Journal of antimicrobial chemotherapy.

Australian medical mycology culture collections: fundamental resources for mycological diagnosis and research

W. Meyer, S. Kidd, D. Ellis, 2019, Microbiology Australia.

Clonality and α-a Recombination in the Australian Cryptococcus gattii VGII Population - An Emerging Outbreak in Australia

V. Robert, B. Currie, F. Carriconde, 2011, PloS one.

Charles Darwin University Clonality and -a recombination in the Australian Cryptococcus gattii VGII population-an emerging outbreak in Australia Carriconde,

V. Robert, B. Currie, F. Carriconde, 2011 .

Synthesis, antifungal, haemolytic and cytotoxic activities of a series of bis(alkylpyridinium)alkanes.

T. Sorrell, K. Jolliffe, D. Obando, 2009, Bioorganic & medicinal chemistry.